HEYL and breast cancer: Accordingly, this BC cell line was chosen to examine Dl1.72 capacity to impair DLL1-Notch signaling by luciferase Notch reporter assay and evaluating the expression levels of the Notch target genes HEY-1 and HEY-L, which are significantly induced by DLL1 [18].